-
Signature
-
/s/ Kristen Williams
-
Issuer symbol
-
PCRX
-
Transactions as of
-
30 Jan 2026
-
Net transactions value
-
-$621,635
-
Form type
-
4
-
Filing time
-
03 Feb 2026, 18:24:01 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| WILLIAMS KRISTEN |
Chief Administrative Officer |
C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE |
/s/ Kristen Williams |
03 Feb 2026 |
0001296965 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PCRX |
Common Stock |
Tax liability |
$351,932 |
-17,134 |
-11% |
$20.54 |
144,440 |
30 Jan 2026 |
Direct |
F1 |
| transaction |
PCRX |
Common Stock |
Sale |
$269,703 |
-13,137 |
-9.1% |
$20.53 |
131,303 |
02 Feb 2026 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: